X. Lataste

480 total citations
21 papers, 365 citations indexed

About

X. Lataste is a scholar working on Psychiatry and Mental health, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, X. Lataste has authored 21 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Neurology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in X. Lataste's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Migraine and Headache Studies (4 papers). X. Lataste is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Migraine and Headache Studies (4 papers). X. Lataste collaborates with scholars based in France, Japan and United Kingdom. X. Lataste's co-authors include Steinar T Vilming, Torstein Lyberg, Murat Emre, Michel D. Ferrari, Yves Agid, A Puech, Y. Lecrubier, L Groves, Caroline Davis and A Rascol and has published in prestigious journals such as Neurology, Pain and Psychopharmacology.

In The Last Decade

X. Lataste

21 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
X. Lataste France	10	150	124	102	68	60	21	365
Stuart Perlik United States	13	217 1.4×	168 1.4×	171 1.7×	47 0.7×	70 1.2×	16	575
Tom�s A. Reader Canada	12	59 0.4×	280 2.3×	58 0.6×	61 0.9×	128 2.1×	17	502
F.W. Vreeling Netherlands	12	348 2.3×	139 1.1×	110 1.1×	19 0.3×	72 1.2×	22	638
Alberto Gottlieb Italy	11	61 0.4×	73 0.6×	144 1.4×	100 1.5×	37 0.6×	15	467
Richard Erspamer United States	8	119 0.8×	164 1.3×	19 0.2×	66 1.0×	76 1.3×	11	363
Michael Klukinov United States	12	63 0.4×	73 0.6×	88 0.9×	29 0.4×	80 1.3×	15	405
Kristopher D. Langdon Canada	14	95 0.6×	74 0.6×	59 0.6×	24 0.4×	59 1.0×	23	519
Francesco Nicoletti Italy	6	121 0.8×	55 0.4×	65 0.6×	22 0.3×	34 0.6×	11	318
Erika Ivanna Araya Brazil	10	68 0.5×	98 0.8×	65 0.6×	95 1.4×	27 0.5×	18	299
Marvin Jay Hoffert United States	11	71 0.5×	261 2.1×	98 1.0×	92 1.4×	66 1.1×	19	601

Countries citing papers authored by X. Lataste

Since Specialization

Citations

This map shows the geographic impact of X. Lataste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Lataste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Lataste more than expected).

Fields of papers citing papers by X. Lataste

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Lataste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Lataste. The network helps show where X. Lataste may publish in the future.

Co-authorship network of co-authors of X. Lataste

This figure shows the co-authorship network connecting the top 25 collaborators of X. Lataste. A scholar is included among the top collaborators of X. Lataste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. Lataste. X. Lataste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lataste, X., Murat Emre, Caroline Davis, & L Groves. (1994). Comparative profile of tizanidine in the management of spasticity.. PubMed. 44(11 Suppl 9). S53–9. 37 indexed citations

Lecrubier, Y., et al.. (1993). A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology. 112(1). 129–133. 52 indexed citations

Duval, Fabrice, et al.. (1993). Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients. Psychopharmacology. 110(1-2). 177–180. 12 indexed citations

Emre, Murat, U. K. Rinne, A Rascol, et al.. (1992). Effects of a selective partil D₁ agonist, CY 208‐243, in de novo patients with Parkinson disease. Movement Disorders. 7(3). 239–243. 34 indexed citations

Lataste, X.. (1992). The Blood-Brain Barrier in Hypoxia. International Journal of Sports Medicine. 13(S 1). S45–S47. 5 indexed citations

Ferrari, Michel D., et al.. (1991). Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. Pain. 45(3). 283–291. 23 indexed citations

Lataste, X., et al.. (1990). Isradipine in Patients with Acute Ischaemic Cerebral Infarction. Drugs. 40(Supplement 2). 52–57. 27 indexed citations

Lang, Anthony E., David E. Riley, Luc Vachon, & X. Lataste. (1990). CQA 206-291 in Parkinson's Disease: An Acute Single Escalating Dosage Study. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 17(4). 416–419. 2 indexed citations

Durrieu, Geneviève, Jean‐Michel Sénard, Olivier Rascol, et al.. (1990). Blood pressure and plasma catecholamines in never‐treated parkinsonian patients. Neurology. 40(4). 707–707. 19 indexed citations

10.

Rascol, Olivier, Nelly Fabre, H. Teräväinen, et al.. (1990). CQA 206–291. Clinical Neuropharmacology. 13(4). 303–311. 2 indexed citations

11.

Lieberman, A. & X. Lataste. (1989). Parkinson's disease : the role of dopamine agonists. 3 indexed citations

12.

Lataste, X., Michel D. Ferrari, Daniel Hirt, Marianne Notter, & Matthew Wilkinson. (1989). Efficacy and Tolerability of ICS 205–930, A 5-HT₃ Receptor Antagonist, in Migraine Prophylaxis. Cephalalgia. 9(10_suppl). 346–347. 4 indexed citations

13.

Temlett, J. A., Niall Quinn, C. D. Marsden, X. Lataste, & A.L. Jaton. (1989). The Antiparkinsonian Activity of CQA 206–291, a New D2 Dopamine Receptor Agonist. Clinical Neuropharmacology. 12(1). 55–59. 2 indexed citations

14.

Temlett, J. A., Niall Quinn, Peter Jenner, et al.. (1989). Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's disease. Movement Disorders. 4(3). 261–265. 46 indexed citations

15.

Ferrari, Michel D. & X. Lataste. (1989). Migraine: And Other Headaches. Medical Entomology and Zoology. 17 indexed citations

16.

Lataste, X., et al.. (1989). A Comparison of DHE Nasal Spray and Cafergot® in Acute Migraine. Cephalalgia. 9(10_suppl). 410–411. 6 indexed citations

17.

Vilming, Steinar T, Torstein Lyberg, & X. Lataste. (1986). Tizanidine in the Management of Trigeminal Neuralgia. Cephalalgia. 6(3). 181–182. 59 indexed citations

18.

Lataste, X.. (1984). The History and Pharmacology of Dopamine Agonists. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 11(S1). 118–123. 5 indexed citations

19.

Lataste, X., et al.. (1981). Comparative study of fluproquazone in the management of post-operative pain.. PubMed. 31(5a). 918–20. 2 indexed citations

20.

Lataste, X., et al.. (1981). Clinical evaluation of fluproquazone in post-operative pain. A report of double-blind comparative trials in patients after surgical interventions.. PubMed. 31(5a). 920–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact